Oncostatin M ELISA (IDK®)

Product code: K6926 (96 wells)

Quantitative determination of oncostatin M in IBD patients

The IDK Oncostatin M (OSM) ELISA is used for the quantitative determination of oncostatin M in serum, plasma or stools. OSM and its receptor, OSMR, are involved in gut inflammation, and are upregulated in the mucosa of IBD patients. The amount of OSM in the gut mucosa can be a predictive biomarker of no response (primary non-response), and loss or response, to anti-TNFα treatment in IBD patients, and could be useful as a diagnostic tool for early stratification of patients to predict the efficacy of treatment.

Download Brochure
Technical Support
Request a Quote

Key Advantages

Quickly indicates risk of anti-TNFα treatment failure in IBD patients
Provides an early stratification tool for patient treatment plans

Specifications

ELISA

41 tests

Storage: 2-8 °C

Blood/stool sample

Related Products

    IDKmonitor Infliximab drug level assay

    Infliximab Drug Level ELISA (IDKmonitor®)

    Infliximab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Infliximab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free infliximab in plasma or serum samples.

    IDKmonitor Infliximab TOTAL anti-drug antibody assay

    Infliximab Total Anti-drug Antibody ELISA (IDKmonitor®)

    Infliximab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response. The IDKmonitor Infliximab Total Anti-drug ELISA kit is a ‘drug tolerant’ assay that enables the detection of anti-drug antibodies in the presence of circulating drug.